Status: Recruiting
Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction
Single-center, double-blind, randomized, controlled intervention study of the effect of correction of bacterial overgrowth syndrome in the small intestine (SIBO) on cardiac function in patients with heart failure with preserved ejection fraction (HFpEF) (SIBO-HFpEF). The aim of the study is to evaluate the efficacy and safety of rifaximin in patients with HFpEF and SIBO.
Participants needed: 40
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: I.M. Sechenov First Moscow State Medical UniversityUpdated: Oct 22, 2024Locations: 1
Eligibility criteria
availability of written informed consent of the patient to participate in the st... [+3]
refusal of the patient from further participation in the study [+1]